Company profile
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole, which is in the first phase for the treatment
- CEO
- Mr. Vininder Singh
- Headquarters
- Gaithersburg, MD, United States
- Employees
- 9
- IPO date
- Feb 13, 2023
- Sector
- Healthcare
- Industry
- Health Information Services